The government has U-turned on its manifesto commitment to offer all workers protection against unfair dismissal from their ...
Acquisition expands Day One’s portfolio with novel antibody-drug conjugate (ADC) emiltatug ledadotin (Emi-Le)Emi-Le has ...
Day One Biopharmaceuticals (DAWN) announced three-year results from the OJEMDA pivotal Phase 2 FIREFLY-1 trial in an oral presentation at the 30th ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback